 Now what we can do is we can get MRI scans of patients and their prostates in particular and with these very specialized MRI scans that we do you can see the area that looks most concerning for cancer And then you can do what's called an MRI targeted biopsy. So rather than just randomly sampling the entire prostate you're actually aiming the needle very precisely within a few millimeters into the area of concern and you're getting Precisely that tissue sampled and analyzed to see if that there's cancer there if we could have a way to diagnose someone that You felt confident that the diagnosis that you're achieving is actually what the patient has You could offer a wider variety of treatments in a more personalized way Treat their tumor in a less aggressive or a more aggressive way than you otherwise would have done That's where this New England journal paper comes into play what this paper Demonstrated was that not only is a target approach better at catching aggressive cancers But it's better at not missing aggressive cancers and that that was the missing piece that it took another five years to really demonstrate